Zobrazeno 1 - 10
of 222
pro vyhledávání: '"E Behr"'
Autor:
H Maclachlan, R Bhatia, H Dhutia, S Fyyaz, N Chatrath, J Basu, C Miles, G Finocchiaro, S Gati, M Specterman, M Tome, A Malhotra, E Behr, S Sharma, M Papadakis
Publikováno v:
European Journal of Preventive Cardiology. 30
Funding Acknowledgements Type of funding sources: Other. Main funding source(s): Cardiac Risk in the Young. Background Sudden cardiac death (SCD) seemingly affects young, healthy individuals and is therefore recognised as an important public health c
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): The Robert Lancaster Memorial Fund sponsored by McColl’s Research Group British Heart Foundation. Background Clinical, electrocardiograph
Clinical trial report: the electrocardiographic response to ajmaline provocation in healthy subjects
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): British Heart Foundation The Robert Lancaster Memorial Fund sponsored by McColl’s Research Group Background The electrocardiographic (ECG) response to diagnostic
Autor:
Y Ben-Haim, A Sangaralingam, A Pittman, A Bird, D Johnson, S Mohiddin, L Favaloro, M Futema, E Behr
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background Previous studies have shown genetic testing in sudden unexpected death in the young (SUDY) cases identify a pathogenic variant in 13-27% of cases. This diagnostic yield increased up t
Publikováno v:
European Heart Journal. 43
Background Sudden cardiac death (SCD) in young individuals and athletes is generally caused by hereditary cardiac conditions, including cardiomyopathies such as hypertrophic cardiomyopathy (HCM). Although historically HCM has been reported as the pre
Publikováno v:
Pharmeuropa bioscientific notes. 2022
Due to the diminished stocks of the third batch of the European Pharmacopoeia (Ph. Eur.) Biological Reference Preparation (BRP) for Human immunoglobulin for electrophoresis, in 2020 the European Directorate for the Quality of MedicinesHealthCare (EDQ
Autor:
CJ Hansen, J Svane, J Isbister, Y Ben-Haim, B Morentin, P Molina, E Behr, J Lucena, C Semsarian, MN Sheppard, J Tfelt-Hansen
Publikováno v:
EP Europace. 24
Funding Acknowledgements Type of funding sources: Public Institution(s). Main funding source(s): University of Copenhagen Introduction Sports-related sudden cardiac deaths (SrSCD) are rare events often occurring in healthy individuals. An underlying
Autor:
M-E, Behr-Gross, B, Siklodi, D, Le Tallec, M, Halder, I, Manou, N, Sinitskaya, L, Bruckner, B, Dalmadi, L, Kiss, K, Redhead
Publikováno v:
Pharmeuropa bioscientific notes. 2021
During the production of clostridial vaccines large numbers of mice are used for various in-process control tests. Replacement in vitro assays had been developed for the testing of the toxins and toxoids of several clostridial species, but none of th
Autor:
J Basu, S Jayakumar, C Miles, G Parry-Williams, H Maclachlan, N Sheikh, P Bulleros, Z Fanton, E Behr, J O’Driscoll, S Sharma, M Tome, D Nikoletou, M Papadakis
Publikováno v:
Young investigators award.
Publikováno v:
Pharmeuropa bioscientific notes. 2020
Three preparations of the human tumour necrosis factor (TNF) receptor II Fc fusion protein (TNFR II-Fc) Etanercept were formulated and lyophilised at the National Institute for Biological StandardsControl (NIBSC) prior to evaluation in a collaborativ